Skip to main content

Search articles in News

Found 2,761 articles

  • Just – Evotec Biologics selected by U.S. Departmen

    Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program

    • 25 Jun 2024
    • Editor

    Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that its Seattle-based subsidiary, Just – Evotec Biologics, Inc., was selected by the U.S. Department of Defense (“DOD”) to develop an accelerated monoclonal antibody (“mAb”) development and manufacturing solution for the DOD’s Manufacturing Optimization Program.

  • Novo Nordisk announces 4.1 billion USD investment

    Novo Nordisk announces 4.1 billion USD investment to expand US manufacturing capacity adline

    • 25 Jun 2024
    • Editor

    Novo Nordisk today announced plans to invest 4.1 billion US dollars (approx 27 billion Danish kroner) to build a second fill and finishing manufacturing facility in Clayton, North Carolina, and grow its ability to produce current and future injectable treatments for people with obesity and other serious chronic diseases.

  • ABBOTT TEAMS UP WITH THE NATIONAL ASSOCIATION OF C

    ABBOTT TEAMS UP WITH THE NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS TO EXPAND ACCESS TO NUTRITIOUS FOOD AND IMPROVE HEALTH

    • 21 Jun 2024
    • Editor

    The global healthcare company Abbott (NYSE: ABT) and the National Association of Community Health Centers (NACHC) have joined together to increase access to healthy foods and improve health through the Innovation Incubator initiative.

  • Radiopharm Receives Strategic Investment for up to

    Radiopharm Receives Strategic Investment for up to A$18 million

    • 21 Jun 2024
    • Editor

    Radiopharm Theranostics Limited (ASX:RAD) (Radiopharm or the Company), a developer of diagnostic and therapeutic radiopharmaceutical products, has entered into strategic agreements with Lantheus Holdings, Inc. (LNTH.NASDAQ), a leading radiopharmaceutical-focused company, and its affiliates (Lantheus).

  • Navigating the Freelance MedComms Consultancy Land

    Navigating the Freelance MedComms Consultancy Landscape

    • 20 Jun 2024
    • Dr Ana Hutanu, MedComms Consultant

    Freelance MedComms Consultants play a pivotal role in the healthcare industry by strategically planning, creating, and facilitating tailored, compliant, accurate, comprehensive, and up-to-date communications of complex medical science, pharmaceutical, bio- and medical technology information among industry stakeholders, healthcare professionals, and patients.

  • Gareth Williams appointed CEO of Bionical Health

    Gareth Williams appointed CEO of Bionical Health

    • 20 Jun 2024
    • Editor

    Bionical Solutions, a leading provider of technology enabled engagement and healthcare services to global pharmaceutical, biotech, healthcare companies and the NHS, today announces the appointment of Gareth Williams as CEO of Bionical Health Ltd.

  • Truqap plus Faslodex approved in the EU for patien

    Truqap plus Faslodex approved in the EU for patients with advanced ER-positive breast cancer

    • 20 Jun 2024
    • Editor

    AstraZeneca’s Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been approved in the European Union (EU) for the treatment of adult patients with estrogen receptor (ER)-positive, HER2‑negative locally advanced or metastatic breast cancer with one or more PIK3CA, AKT1, or PTEN-alterations following recurrence or progression on or after an endocrine-based regimen.

  • Roche launches new highly-sensitive test to more e

    Roche launches new highly-sensitive test to more easily diagnose patients who may have B-cell lymphoma

    • 20 Jun 2024
    • Editor

    Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of the first clinically approved, highly-sensitive in-situ hybridisation (ISH) test, the VENTANA® Kappa and Lambda Dual ISH mRNA Probe Cocktail assay, in countries accepting the CE Mark.

  • How to Build a Diverse Medical Writing Portfolio

    How to Build a Diverse Medical Writing Portfolio

    • 19 Jun 2024
    • Lucy Walters

    In an ever-evolving field like medical writing, versatility is not just a skill – it’s a necessity. As the demands of the healthcare sector grow increasingly complex, you should be looking for new ways to diversify your portfolio and effectively demonstrate your range of skills and depth of knowledge.

  • Boston Scientific Announces Agreement to Acquire S

    Boston Scientific Announces Agreement to Acquire Silk Road Medical, Inc.

    • 19 Jun 2024
    • Editor

    Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Silk Road Medical, Inc. (Nasdaq: SILK), a medical device company that has developed an innovative platform of products to prevent stroke in patients with carotid artery disease through a minimally invasive procedure called transcarotid artery revascularization (TCAR).

  • Eckert & Ziegler and UJF Open State-of-the-Art Act

    Eckert & Ziegler and UJF Open State-of-the-Art Actinium-225 Production Facility

    • 19 Jun 2024
    • Editor

    Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler), in collaboration with the Nuclear Physics Institute of the Czech Academy of Sciences (Ústav jaderné fyziky, “UJF”), announces the grand opening of a pioneering Actinium-225 (Ac-225) production facility.

  • Thermo Fisher Scientific Expands Clinical Research

    Thermo Fisher Scientific Expands Clinical Research Laboratory in Wisconsin

    • 19 Jun 2024
    • Editor

    The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled a new clinical research laboratory building at its good manufacturing practices (GMP) lab in Middleton, Wisconsin.

  • Labcorp Launches Global Trial Connect to Accelerat

    Labcorp Launches Global Trial Connect to Accelerate Clinical Trials

    • 18 Jun 2024
    • Editor

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Labcorp Global Trial Connect, a suite of central laboratory solutions aimed at increasing the speed of clinical trials where the heart of clinical research is conducted – investigator sites.

  • Make World Dengue Day a Reality

    Make World Dengue Day a Reality

    • 17 Jun 2024
    • Editor

    Whilst WDD is widely backed and recognised on 15th June by the International Society for Neglected Tropical Diseases (ISNTD), Asian Dengue Voice and Action (ADVA) Group and dengue scientists around the world, it is not yet recognised by the United Nations.

  • Onyx Scientific Aims for European Growth with New

    Onyx Scientific Aims for European Growth with New BD Hire

    • 14 Jun 2024
    • Editor

    Leading small molecule CDMO Onyx Scientific has its sights set on European-wide commercial expansion with the new appointment of Courtnie Thomas Wilks as Business Development Manager for the UK and Europe.

  • BioMed X Launches New US Institute in New Haven, C

    BioMed X Launches New US Institute in New Haven, CT

    • 14 Jun 2024
    • Editor

    BioMed X, an independent research institute founded in Heidelberg, Germany, has expanded its operations with the opening of a new institute in the United States. Located in New Haven, CT, in the vicinity of Yale University, the new facilities are part of the Elm City Bioscience Center, a state-of-the-art lab and research building owned by The Hurley Group.

  • BONESUPPORT™ APPOINTS ANNA STEGMARK EVP QM & RA

    BONESUPPORT™ APPOINTS ANNA STEGMARK EVP QM & RA

    • 13 Jun 2024
    • Editor

    BONESUPPORT AB a leading company in orthobiologics for the management of bone injuries, today announces that Anna Stegmark has been appointed EVP Quality Management & Regulatory Affairs with effect from 1 July 2024. She will also be part of the management team.

  • From Medicine to Freelance MedComms Consultancy: A

    From Medicine to Freelance MedComms Consultancy: A Personal Experience

    • 13 Jun 2024
    • Dr Ana Hutanu, MedComms Consultant

    Transitioning from a Medical Doctor's traditional path to the world of a Freelance MedComms Consultant has been exciting and seasoned with opportunities. This shift has allowed me to leverage my extensive international medical training, teaching, and biomedical research experience and introduced me to a world where flexibility, continuous learning, and building long-standing client relationships are paramount.

  • Current State of the Regulatory Contract Recruitme

    Current State of the Regulatory Contract Recruitment Market in the Life Science Industry

    • 11 Jun 2024
    • Jasmine Smith, ARM

    The regulatory contract recruitment market within the life science industry is currently experiencing significant growth and transformation. Over the last year or so, the market has been difficult, marked by unpredictability and challenges.

  • Macomics Announces Appointment of Simon Dew as New

    Macomics Announces Appointment of Simon Dew as New Chief Business Officer

    • 11 Jun 2024
    • Editor

    Macomics Ltd, a leader in macrophage drug discovery has announced the appointment of Simon Dew in the newly created position of Chief Business Officer (CBO). He will be instrumental in advancing Macomics’ mission to develop first-in-class medicines targeting macrophage-driven diseases of high unmet medical need, in oncology and chronic inflammatory diseases.